ArticleBMC cancer2015

KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin [corrected] in prostate cancer models.

Giovanni Luca Gravina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.